
The critical need for alternative approaches to address antibiotic treatment failure – by Bob Hancock
moreCOVID-19: Pourquoi il est plus important que jamais de s’attaquer à la crise silencieuse des infections résistantes aux médicaments – ...
more
Probability of target attainment analyses for dose selection in antimicrobial drug development
more
COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram
more
PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
more
Bringing antimicrobial research and development to Africa – the time is now – by Greg Basarab and Kelly Chibale
more
Are new antibiotic combinations the solution to the AMR crisis? – by Anthony Coates
more
Ramesh Agarwal
Professor of Paediatrics
All India Institute of Medical Sciences
more

M. Javad Aman
President
Integrated BioTherapeutics, Inc.
more

Jeffrey Ambroso
Toxicologist
RTI International
more